Search research articles
Contact Us
Filters
Showing results (211-220 of 227) with videos related to
Page
of 23
Sort By:
British Journal of Cancer
|
January 28, 2010
p53 mutation, deprivation and poor prognosis in primary breast cancer
L Baker, P R Quinlan, N Patten, et al.
Annals of Surgical Oncology
|
June 28, 2018
Multidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive Margins
S E Tevis, H B Neuman, E A Mittendorf, et al.
Journal of Geophysical Research. Atmospheres : JGR
|
April 23, 2019
Balance of Emission and Dynamical Controls on Ozone During the Korea-United States Air Quality Campaign From Multiconstituent Satellite Data Assimilation
K Miyazaki, T Sekiya, D Fu, et al.
Journal of Kidney Cancer and VHL
|
December 16, 2024
Is the TriNetX Database a Good Tool for Investigation of Real-World Management of Von Hippel-Lindau?
Aaron R Hochberg, Patrick T Gomella, Brian Im, et al.
Oncogene
|
April 5, 2016
The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer
X Mao, C Gauche, M W H Coughtrie, et al.
Journal of Atmospheric Chemistry
|
December 23, 2015
Estimating surface NO<sub>2</sub> and SO<sub>2</sub> mixing ratios from fast-response total column observations and potential application to geostationary missions
T Knepp, M Pippin, J Crawford, et al.
Annals of Surgical Oncology
|
December 18, 2018
OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients
S E Tevis, R Bassett, I Bedrosian, et al.
Journal of Medicinal Chemistry
|
November 7, 2000
3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinase
A M Thompson, C J Connolly, J M Hamby, et al.
Oncogene
|
May 24, 2011
Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma
S A Watt, C Pourreyron, K Purdie, et al.
Journal of Medicinal Chemistry
|
February 14, 1997
Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners
H D Showalter, A D Sercel, B M Leja, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 227) with videos related to
Sort By:
Page
of 23
British Journal of Cancer
|
January 28, 2010
p53 mutation, deprivation and poor prognosis in primary breast cancer
L Baker, P R Quinlan, N Patten, et al.
Annals of Surgical Oncology
|
June 28, 2018
Multidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive Margins
S E Tevis, H B Neuman, E A Mittendorf, et al.
Journal of Geophysical Research. Atmospheres : JGR
|
April 23, 2019
Balance of Emission and Dynamical Controls on Ozone During the Korea-United States Air Quality Campaign From Multiconstituent Satellite Data Assimilation
K Miyazaki, T Sekiya, D Fu, et al.
Journal of Kidney Cancer and VHL
|
December 16, 2024
Is the TriNetX Database a Good Tool for Investigation of Real-World Management of Von Hippel-Lindau?
Aaron R Hochberg, Patrick T Gomella, Brian Im, et al.
Oncogene
|
April 5, 2016
The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer
X Mao, C Gauche, M W H Coughtrie, et al.
Journal of Atmospheric Chemistry
|
December 23, 2015
Estimating surface NO<sub>2</sub> and SO<sub>2</sub> mixing ratios from fast-response total column observations and potential application to geostationary missions
T Knepp, M Pippin, J Crawford, et al.
Annals of Surgical Oncology
|
December 18, 2018
OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients
S E Tevis, R Bassett, I Bedrosian, et al.
Journal of Medicinal Chemistry
|
November 7, 2000
3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinase
A M Thompson, C J Connolly, J M Hamby, et al.
Oncogene
|
May 24, 2011
Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma
S A Watt, C Pourreyron, K Purdie, et al.
Journal of Medicinal Chemistry
|
February 14, 1997
Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners
H D Showalter, A D Sercel, B M Leja, et al.
Page
of 23